Judging junk science: Here are the tools available for the courts to identify and block predatort and activist misinformation

Screenshot 2026-01-26 at 10.18.36โ€ฏAM

Much has been written advising laypeople to navigate conflicting medical opinions and identify the golden truth amid the pervasive muck and mire. These questions also vex judges when evidence is presented in litigation seeking damages from allegedly related injuries. Although judges do not decide which of the competing positions is correct, they are, as the evidentiary โ€œgatekeeper,โ€ responsible for determining the soundness of the science presented and barring junk science from the courtroom. Once assessed, all sound evidence from both sides is presented to the jury for deliberation, essentially based on which witness they found most credible. Whether the decision is made by a judge or a jury, specific, albeit different, strategies are used to make these assessments.

From Frye to Daubert

From 1923 to 1993, a judge could only admit novel claims if the consensus of the relevant scientific community supported it โ€“ the Frye standard.  This prevented the introduction of cutting-edge science or emerging critiques by younger researchers, muzzling newcomers who criticized existing dogma. 

Realizing that Frye chilled the admissibility of cutting-edge science views, in 1970, the Federal Rules of Evidence broadened the standard, allowing all evidence as long as it was based on sound science, and relied on the practice of cross-examination to ferret out uncredible experts.  In 1993, the Supreme Court clarified their position in Daubert v. Merrell Dow, now adopted in all federal courts and all but six states.  Daubert and subsequent cases refined the standards for distinguishing between sound and junk science even further.  (It must be noted that lawyersโ€™ name-calling established science as junk doesnโ€™t necessarily make it so and often serves as a public relations tactic.) 

The Daubert standard does not give carte blanche to any new theory, nor to all novel claims.  It sets forth theoretical parameters that must be satisfied before a jury can consider the evidence: reliability, relevance, and โ€œthe fitโ€ of the evidence and the research to the facts of the case, implicitly requiring compliance with the scientific method in the research relied on.  It also imposes on the judge the role of gatekeeper โ€“ policing problematic or pseudo-science.  Later cases expanded Daubert and required any expert opinion to be tethered to the methodology and the research, disallowing experts from pontificating or opining purely on personal assessment.  The focus on Daubert was on the scientific soundness of the methodology; the Joiner case expanded the focus to the legitimacy of the expertโ€™s conclusion.

Scientific reliability is usually measured by statistical significance; the validity or relevance standard may be satisfied if the research is performed in conformity with the methodological norms of the particular field, yielding objective results.  Daubert suggests additional, optional tests judges may use to evaluate claims:

  • Whether the underlying research was peer-reviewed and published. 
  • Whether the theory was tested via experiment and yielded objective results.
  • Whether an acceptable error rate was calculated.
  • Consideration of the Frye index of acceptance, scientific consensus. 

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

In 1993, when Daubert was decided, there were far fewer medical journals, and most were published by independent, reputable houses that relied on impeccable experts to review.  Today, the number of journals has mushroomed, along with fraudulent research (some of which is later retracted), and many articles and journals are financed by organizations supporting the claims being litigated.  This has weakened the Daubert standard, although there are some practical remedies. 

  • Identify retracted studies, for example, through databases, like Retraction Watch
  • Identify the financial and ideological conflicts of interest of both the publisher and the author
  • Investigate the Impact Factor, a measure of a journalโ€™s impact, on the scientific community
  • Assess the editorial board’s prestige and partisan ties to industry or ideological groups

Following its overarching decision on the role of a judge in evaluating scientific evidence, the Supreme Court sent the Daubert case back to the 9th Circuit to implement its rulings in the context of the facts of the case (Does Bendectin, an anti-nausea drug, cause birth defects if ingested during pregnancy?) The latter opinion provides yet additional considerations for judicial assessment, noting :

โ€œexpert opinion based on a methodology that diverges “significantly from the procedures accepted by recognized authorities in the field … Are not ‘generally accepted as a reliable technique.โ€™โ€ 

Of major concern to the court is the independence of the expertโ€™s research:

 โ€œ testimony proffered by an expert โ€ฆ based directly on legitimate, preexisting research unrelated to the litigation provides the most persuasive basis for concluding that the opinions he expresses were “derived by the scientific method. โ€ฆ Experts who have developed their opinions expressly for purposes of testifying are not favored under Daubertโ€ฆ. Independent research carries its own indicia of reliability, โ€ฆ.โ€

When evaluating the value of even a noted expert, it is worth noting when their first research on the subject was published – before or after being retained by either side of the controversy? 

The Cherry-Picker

Another bug-a-boo of gatekeepers is โ€œthe Chinese Menuโ€ philosophy (called cherry-picking, by the courts)- when experts rely solely on cases supporting their position, discounting those that donโ€™t, without explaining any reasonable and consistent basis or methodology for this approach, i.e.,  poor study design or small number of subjects.

Numerous judges have rejected the cherry-picking expert, including in the NY Acetaminophen-Autism cases and the federal and Delaware Zantac cases.  Although this decision reflects judicial discretion, it is rarely disturbed on appeal; however, several of these are currently on appeal, and we will soon learn the validity of judicial rejection on this ground.

Another clue of judicial disfavor occurs when courts reject reanalysis of epidemiological studies that had neither been published nor subjected to peer review, finding unpublished reanalysis “particularly problematic in light of the massive weight of the original published studiesโ€ฆ all of which had undergone full scrutiny from the scientific community.”

But what happens if there is research both in favor of and opposing an expertโ€™s position?  After judicial determination that all proffered scientific evidence is sound, i.e., reliable, relevant, and fit, it is submitted for jury consideration, and less significant infirmities, including witness credibility, are intended to be exposed via cross-examination.

Games People Play: The Publication Version

Publication still plays a significant role in presenting an expertโ€™s views as authoritative. 

Generally speaking, reputable journals, as well as pre-peer-reviewed publication sites, like the Social Science Research Network, require a declaration of conflict of interest, financial or ideological, and these can be used to assess the impartiality of the editors and authors.

Another โ€œlook goodโ€ tactic used by unreliable groups or authors cites various articles that appear impressive but, on review, do not sustain the underlying premise.  That means itโ€™s critical to check the researchersโ€™ cited literature, much as courts check the underlying cases relied on to support legal arguments.  In the age of AI, where hallucinated sources are not uncommon, this practice becomes mandatory.  Another tactic is to cite a purported article in a mainstream publication, only to learn that it is nothing more than a Letter to the Editor, which generally are not peer-reviewed, are often composed by industrial or ideological advocates, and sometimes involve official associations and financial conflicts of interest.

While these partisan pieces may be exposed during cross-examination during litigation, it is up to you, dear reader, to read the primary study and check its citations if issues arise before litigation ensues. 

While even reputable publications, such as The Lancet and the New England Journal of Medicine, have published articles that turned out to be erroneous (and must be verified by replicated research), valid research and information on the internet is being pulled by the government when the outcome may conflict with a political position, depriving readers of valid alternative research.  The antidote isnโ€™t clear.

At the end of judicial analysis comes the question, who is objecting, and what interests do they have in the outcome?  The same analysis should apply to critiques of position papers in journals or internet publications like ours.  Who wrote the critique, and what do they have to gain? 

Dr. Barbara Pfeffer Billauer, JD, MA (Occ. Health) Ph.D, is Professor of Law and Bioethics in the International Program in Bioethics of the University of Porto and Research Professor of Scientific Statecraft at the Institute of World Politics in Washington, DC. 

A version of this article was originally posted atย American Council on Science and Healthย and is reposted here with permission. Any reposting should credit both the GLP and the original article. Find ACSH on Xย @ACSHorg

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpointโ€”โ€œMiracle moleculeโ€ debunked: Why acemannan supplements donโ€™t work
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
Screenshot 2026-05-26 at 10.15
Viewpoint: Double standardโ€”Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
ChatGPT-Image-Jun-4-2026-01_27_58-PM
Viewpointโ€”N.A.D.+: Why Gwenyth Paltrowโ€™s heralded anti-aging supplement doesnโ€™t work
downsyndrome_compilation_MID_1
CRISPR breakthrough that can remove the chromosome responsible for Down syndrome raises ethical questions
ChatGPT-Image-May-26-2026-07_51_21-AM-2
Viewpoint: There are more than 1,000 chemicals in a cup of coffeeโ€”including many substances that can cause cancer. Why isnโ€™t it banned?
tick-DNA
GLP podcast: Spread meat allergy with gene-edited ticks? Bioethicists pose vile โ€˜thought experimentโ€™

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.